Notable sequence homology of the ORF10 protein introspects the architecture of SARS-COV-2
By
Sk. Sarif Hassan,
Diksha Attrish,
Shinjini Ghosh,
Pabitra Pal Choudhury,
Vladimir N Uversky,
Bruce D Uhal,
Kenneth Lundstrom,
Nima Rezaei,
Alaa A. A. Aljabali,
Murat Seyran,
Damiano Pizzol,
Parise Adadi,
Tarek Mohamed Abd El-Aziz,
Antonio Soares,
Ramesh Kandimalla,
Murtaza Tambuwala,
Amos Lal,
Gajendra Kumar Azad,
Samendra P Sherchan,
Wagner Baetas-da-Cruz,
Giorgio Palù,
Adam M Brufsky
Posted 06 Sep 2020
bioRxiv DOI: 10.1101/2020.09.06.284976
The global public health is endangered due to COVID-19 pandemic, which is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Despite having similar pathology to MERS and SARS-CoV, the infection fatality rate of SARS-CoV-2 is likely lower than 1%. SARS-CoV-2 has been reported to be uniquely characterized by the accessory protein ORF10, which contains eleven cytotoxic T lymphocyte (CTL) epitopes of nine amino acids length each, across various human leukocyte antigen (HLA) subtypes. In this study, all missense mutations found in sequence databases were examined across twnety-two unique SARS-CoV-2 ORF10 variants that could possibly alter viral pathogenicity. Some of these mutations decrease the stability of ORF10, e.g. I4L and V6I were found in the MoRF region of ORF10 which may also possibly contribute to Intrinsic protein disorder. Furthermore, a physicochemical and structural comparative analysis was carried out on SARS-CoV-2 and Pangolin-CoV ORF10 proteins, which share 97.37% amino acid homology. The high degree of physicochemical and structural similarity of ORF10 proteins of SARS-CoV-2 and Pangolin-CoV open questions about the architecture of SARS-CoV-2 due to the disagreement of these two ORF10 proteins over their sub-structure (loop/coil region), solubility, antigenicity and change from the strand to coil at amino acid position 26, where tyrosine is present. Altogether, SARS-CoV-2 ORF10 is a promising pharmaceutical target and a protein which should be monitored for changes which correlate to change pathogenesis and clinical course of COVID-19 infection. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 387 times
- Download rankings, all-time:
- Site-wide: 64,987
- In bioinformatics: 6,332
- Year to date:
- Site-wide: 14,337
- Since beginning of last month:
- Site-wide: 12,367
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!